Medicine for treating diabetic angiopathy

A technology of diabetic blood vessels and external drugs, applied in the field of pharmacy, to achieve good results, relieve eye pressure, and improve the quality of life

Inactive Publication Date: 2016-05-25
济南思拓新源医药科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Diabetic retinopathy is one of the vascular complications of diabetes. It is very important to start treatment at the early stage of complications. At...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Embodiment 1 oral medicine capsule

[0059]The embodiment of the present invention provides an oral medicine for treating diabetic retinopathy with deficiency of both qi and yin, which is made of the following raw materials in parts by weight: 16 parts by weight of ginseng, 15 parts by weight of lily, and 12 parts by weight of yellow-footed chicken 23 parts by weight of Ganoderma lucidum, 19 parts by weight of seaweed, 15 parts by weight of sea snail, 13 parts by weight of tiger tail wheel, 3 parts by weight of evening primrose oil, 2 parts by weight of fruit root on the leaf, 14 parts by weight of Chinese cabbage, 13 parts by weight of wolfberry leaf parts by weight and licorice 11 parts by weight;

[0060] Its preparation method is specifically:

[0061] The first step is to mix the raw materials of the traditional Chinese medicine in proportion, add ethanol with an alcohol concentration of 90% that is three times the mass of the mixture, heat and reflux for 2 hours,...

Embodiment 2

[0064] Embodiment 2 medicine tablet for oral administration

[0065] The embodiment of the present invention provides an oral medicine for treating diabetic retinopathy with deficiency of both qi and yin, which is made of the following raw materials in parts by weight: 16 parts by weight of ginseng, 15 parts by weight of lily, and 12 parts by weight of yellow-footed chicken 23 parts by weight of Ganoderma lucidum, 19 parts by weight of seaweed, 15 parts by weight of sea snail, 13 parts by weight of tiger tail wheel, 3 parts by weight of evening primrose oil, 2 parts by weight of fruit root on the leaf, 14 parts by weight of Chinese cabbage, 13 parts by weight of wolfberry leaf Parts by weight, 11 parts by weight of licorice, 15 parts by weight of Acanthopanax, 8 parts by weight of sweet potato, 13 parts by weight of Panlong ginseng, 14 parts by weight of dog ants and 9 parts by weight of sheep dung fruit;

[0066] Its preparation method is specifically:

[0067] The first ste...

Embodiment 3

[0070] Embodiment 3 medicine for external use pastes umbilical agent

[0071] The present invention also provides an external medicine for treating diabetic vascular disease. The external medicine is made of the following raw medicinal materials in parts by weight: 13 parts by weight of angelica, 10 parts by weight of ginseng, 21 parts by weight of ganoderma lucidum, and 16 parts by weight of sheep dung fruit part, 11 parts by weight of medlar and 6 parts by weight of Radix Glycyrrhizae;

[0072] Its preparation method is specifically:

[0073] In the first step, the raw medicinal materials are mixed in proportion, crushed into 50-mesh powder, and ethanol with an alcohol concentration of 90% that is three times the mass of the mixture is added, heated and refluxed for 2 hours, extracted, and filtered to obtain the first extract; The medicinal residue obtained by filtering is then added with ethanol with an alcohol concentration of 90% relative to the mass of the medicinal res...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a medicine for treating diabetic angiopathy. The medicine comprises an orally taken medicine and an externally applied medicine; the orally taken medicine comprises Radix Ginseng, Bulbus Lilii, Rhizoma disporopsis pernyi, Ganoderma Lucidum Karst, Thallus Porphyrae, Radix Codonopsis lanceolatae, Herba Urariae crinitae, Radix Oenotherae erythrosepalae oil, Radix Tiliae, Plantula Brassicae chinensis, Folium Ilicis Cornutae and Radix Glycyrrhizae; and the externally applied medicine comprises Radix Angelicae Sinensis, Radix Ginseng, Ganoderma Lucidum Karst, Fructus syzygii cumini, Fructus Lycii and Radix Glycyrrhizae. The medicine has the beneficial effect that the medicine comprises the orally taken medicine and the externally applied medicine, the orally taken medicine and the externally applied medicine are used jointly and interwork, the medicine takes effect quickly and is good in effect when used for clinically treating diabetic retinopathy caused by deficiency of both Qi and Yin, eye pressure can be relieved effectively, retinal neovascularization is reduced effectively, vision of a patient is improved, living quality of the patient is improved, meanwhile, the medicine is high in safety and does not have toxic or side effects, and the disease is difficult to recur.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a medicine for treating diabetic vascular disease. Background technique [0002] Diabetic vascular disease is one of the common complications of diabetes, which is also one of the main causes of death in diabetic patients. The most common vascular diseases include cardiovascular disease, cerebrovascular disease, kidney, retina and skin microvascular disease, etc. Diabetic retinopathy (DR) is the most important manifestation of diabetic microangiopathy, a fundus lesion with specific changes, and one of the serious complications of diabetes. Clinically, based on the presence or absence of retinal neovascularization as a sign, diabetic retinopathy without retinal neovascularization is called non-proliferative diabetic retinopathy (NPDR) (or simple type or background type), while retinal neovascularization will be The resulting diabetic retinopathy is called proliferative diabeti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8967A61K36/815A61K36/898A61P3/10A61P9/10
CPCA61K36/258A61K9/0048A61K9/08A61K9/2054A61K9/4858A61K9/7023A61K36/02A61K36/074A61K36/185A61K36/232A61K36/254A61K36/31A61K36/344A61K36/48A61K36/484A61K36/61A61K36/815A61K36/8945A61K36/896A61K36/8967A61K36/898A61K2300/00
Inventor 王保国
Owner 济南思拓新源医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products